Background: Doxorubicin (DOX) is an effective antineoplastic drug indicated to treat many cancerous diseases but its clinical usefulness is limited by many side effects. The main and the most serious one is DOX induced cardiotoxicity. Many strategies have been tried to minimize this side effect such as addition of cardioprotective agent to DOX treatment protocols. Aims: The aim of this work was directed to investigate whether marine astaxanthin (ATX), a xanthophyll carotenoid pigment with potent antioxidant effect, could protect heart against the cardiotoxicity induced by DOX. Methodology: Forty Male Wister rats were divided into four equal groups and treated for one week as follow: Group I rats were treated with normal saline (2 ml/kg, x7, i.p.) and considered a control group. Group II rats were treated with ATX (40 mg/kg, x7, i.p.). Group III rats were treated with AlQahtani et al.; JPRI, 27(3): 1-11, 2019; Article no.JPRI.48804 2 normal saline (2 ml/kg, x7, i.p.) and a single dose of DOX (20 mg/kg, i.p.) at day 7. Finally, group IV rats were treated with ATX (40 mg/kg, x7, i.p) and with a single dose of DOX (20 mg/kg, i.p.) at day 7. After 24 and 48 hrs of treatment, rats were anesthetized and prepared for collection of blood samples and heart isolation. The cardioprotective effect of ATX against DOX induced cardiotoxicity were evaluated by measurement of the serum level of cardiac enzymes CPK by colorimetric assay and CK-MB by Eliza. Also the levels of serum total antioxidant capacity (TAC) were measured colorimetrically. In addition, the Malondialdehyde (MDA), reduced glutathione, glutathione peroxidase (GPx) levels and superoxide dismutase (SOD) were determined in heart tissues homogenate by colorimetric method. In addition, Heart sample were taken for histopathology studies. Results: The Addition of ATX to DOX significantly (p<0.05) decreased the serum level of cardiac enzymes (CPK, CK-MB) and increased the serum total antioxidant capacity in compare with these levels in sera of rats treated with DOX only. This addition also significantly decreased the level of malondialdehyde and increased the reduced glutathione and glutathione peroxidase and superoxide dismutase significantly in the heart tissues homogenate in compare to corresponding levels in rats treated with DOX alone. Histopathological investigation of cardiac tissues confirmed the biochemical studies, where addition of ATX to DOX treatment protocol showed that the fragmentation of the muscle fiber revealed normal with central vesicular nuclei and prevented a marked disruption of normal cardiac architecture which resulted from DOX treatment. Conclusion: Marine astaxanthin provides excellent cardioprotective effect against doxorubicin induced cardiotoxicity in rats.
INTRODUCTION
Doxorubicin was firstly used clinically in cancer therapy in the late 1960s. It is considered as one of the most potent antitumor anthracyclines. DOX could be administered alone or with other chemotherapeutic agents in the treatment protocols of many types of cancers such as leukemias, lymphomas, soft-tissue sarcomas and solid tumors. Unfortunately, its cytotoxic effects are limited by its cardiotoxicity [1, 2] , the main side effect of DOX, which could lead to congestive heart failure [3] . It has been reported that the cardiomyopathy and congestive heart failure after treatment with DOX is dosedependent [4, 5] . Doxorubicin induces its cardiotoxicity by many mechanisms such as DNA and RNA damages, induction of oxidative stress through liberation of reactive oxygen specious, lipid peroxidation, increase the endoplasmic reticulum-mediated apoptosis, inhibition of autophagy and interference with of calcium homeostasis [2, 6] . In addition, DOX metabolism produces superoxide anion and hydroxyl radical which lead to toxic manifestation in the cellular membrane of the normal cells. Also, it has been reported that this toxicity is mediated through cardiac tissues inflammation [7] . Between the importance of DOX in cancer treatment and the increase of the incidence of its induced cardiotoxicity, it has become increasingly important to find pharmacological remedies with protective effects against this serious side effect [7, 8] . Variety of approaches have been Investigated as the addition of natural compound with chemopreventive or anticancer properties to the DOX treatment protocol [9, 10, 11] . Astaxanthin is a natural reddish carotenoid pigment belongs to the xanthophylls family. It has a potent antioxidant, antitumor, antiinflammatory, anti-lipid peroxidation and cardioprotective effects [12, 13, 14] . Intraperitoneal administration of ATX leads to faster absorption with higher bioavailability than oral administration in oncorhynchus mykiss [15] . ATX is extensively distributed in all tissues after an oral administration and metabolized by CYP1A following oral ingestion in the rat [16] . The plasma ATX elimination half-life was estimated to be 21 ± 11 hr. after oral dose in human [17] . In our laboratory, we found that ATX potentiated the cytotoxic activity of DOX against the growth of Ehrlich ascites carcinoma cells in vivo (data not shown). Therefore, the present study was undertaken to test whether ATX could protect the heart against DOX-induce cardiotoxicity in normal rats through prevention of oxidative stress. 
MATERIALS AND METHODS

Drugs and Chemicals
Animals and Housing
Male Wistar Albino rats (8-10 weeks of age, 250-300 gm. b.wt.) were provided from the animal house at College of Pharmacy, King Abduaziz University, Jeddah, Saudi Arabia. The rats were acclimatized for 7 days before experiments. A commercial balanced diet and water ad libitum were provided all over the experiments.
Experimental Design
Forty Male Wister rat were randomly distributed into four equal groups, 10 animals in each group. Rats of group I were injected with normal saline (2 ml/kg, x7, i.p.) and considered as control group. group II animals were treated with ATX (40 mg/kg, x7, i.p.). Rats of group III were treated with normal saline (2 ml/kg, x7, i.p.) and a single dose of DOX (20 mg/kg, i.p.) at day 7. Finally, group IV rats were treated with ATX (40 mg/kg, x7, i.p) and at day 7 treated with a single dose of DOX (20 mg/kg, i.p.). After 24 and 48 hrs of treatment, rats were anesthetized and prepared gently for collection of blood samples in nonheparinized tubes from each rat by cardiac puncture according to the IACUC recommended standard methods for blood collection. The samples were left to clot for 30 minutes then centrifuged for serum separation which was stored at − 80°C to evaluate different biochemical parameters.
Evaluation of Cardiotoxicity of DOX
Treatment in Presence and Absence of ATX
Evaluation of Serum Creatine Phosphokinase (CPK)
Creatine kinase activity was determined colorimetrically using CPK kit (Centronic GmbH, Germany) according to the method of Szasz et al. [18] .
Evaluation of Serum Creatine Kinase MB isoenzyme (CK-MB)
The serum level of CKMB was evaluated in rats' serum using rat creatine kinase MB isoenzyme, CK-MB ELISA Kit, according to the manufacturer protocol.
Measurement of serum antioxidants activities and oxidative stress
The Total serum antioxidant capacity was measured by colorimetric method, according to the method of Koracevic et al. [19] . In the heart tissues homogenate the reduced glutathione was measured according to the method of Beutler et al. [20] . GPx was determined by colorimetric method according to the method of Paglia et al. [21] and Malondialdehyde level was determined by colorimetric method according to the method of Ohkawa et al. [22] . SOD was measured colorimetrically in the cardiac tissues homogenate according to the method of Nishikimi et al. [23] .
Histopathological Examination
After blood collection, rats were sacrificed by gently decapitation, chest opened and hearts were extracted. Heart sample was taken immediately and washed with saline. Part of the left ventricle of the heart was fixed in10% phosphate buffered formalin and processed for paraffin blocks. Serial histological longitudinal sections of 5-µm thickness were cut, mounted on glass slides and stained with haematoxylin and eosin (H&E) for general structure [24] . Half gm. of the remaining cardiac tissues was homogenized in 5 ml of phosphate buffer saline on ice, using an electric homogenizer (Potters, German).
Statistical Analysis
Statistical analysis of the data was carried out using computer program package (SPSS, version 21). All data are expressed as mean with their standard error of mean (SEM). One-way analysis of variance (ANOVA) was used to compare differences between experimental groups. It was followed by the least significance difference (LSD) test. However, two-sample t-test and its P-value to analyze the significance of the difference in the samples mean. Differences were considered significant at P < 0.05. Table 4 showed the effect of DOX and/or ATX on GSH level in rat's heart homogenate. There were significant decreases (1.7 and 1.8 fold) in GSH level in DOX treated rats compared with control after 24 and 48 hrs. of treatment, respectively. While, in presence of ATX the GSH levels maintained nearly to the normal values (104.6 and 104.78 mg/g tissue) respectively. Table 5 showed the effect of DOX and/or ATX on MDA level in the rat's heart homogenate. There were significant increases (3.5 and 3. Table 5 showed the effect of DOX and/or ATX on MDA level in the rat's heart homogenate. There were significant increases (3.5 and 3.7 fold) in MDA level in DOX treated rats compared with control after 24 and 48 hrs of treatment, respectively. While, addition of ATX to DOX showed a significant reduction in MDA levels and return it nearly to normal values (47.10 nmol/g tissue and 43.30 nmol/g tissue) after 24 and 48 hrs of treatment, respectively. Tables 6 showed the effects of DOX on rat heart homogenate. GPx level in rat heart has been decreased after DOX treatment, while in presence of ATX, GPx levels maintained nearly to normal values (4.60, 5.21 U/mg. tissue) after 24 and 48 hrs. of treatment, respectively ( 6). Table 7 represented the effect of DOX and/or ATX on SOD activity in rats' serum. There were significant decreases (1.6 and 1.72 fold) in SOD activity in DOX treated rats compared to control after 24 and 48 hrs. of treatment, respectively. Addition of ATX to DOX, maintaining the SOD activity nearly to the normal values (3.35 and 4.01 U/ml). , addition of ATX to DOX showed a significant reduction in MDA levels and return it nearly to normal values (47.10 nmol/g tissue and 43.30 nmol/g tissue) after 24 and 48 Tables 6 showed the effects of DOX on GPx in rat heart homogenate. GPx level in rat heart has been decreased after DOX treatment, while in presence of ATX, GPx levels maintained nearly to normal values (4.60, 5.21 U/mg. tissue) after 24 and 48 hrs. of treatment, respectively ( Table   Photomicrograph of Light photomicrograph (Fig. 4) showed the effect of DOX (20 mg/kg) treatment on the myocardium tissues of the rats. DOX treatment showed a marked disruption of normal cardiac architecture, congestion of blood vessels and capillaries, condensed pyknotic peripheral nuclei and multiple areas of fragmented cardiac muscle fibers.
RESULTS
Effect of DOX and/or ATX on Cardiac Enzymes
Effect of DOX and/or ATX on the Serum Antioxidant Capacity
Effect of DOX and/or ATX on Lipid Peroxidation in the Rats Cardiac
Histopathological Investigation after Treatment with DOX and/or ATX
These changes have been attenuated when pretreated with ATX. Treatment with DOX (20 mg/kg) + ATX (40 mg/kg) showed that most of cardiac muscle fibers regained its normal structure but localized areas of myocytolysis and shortening of cardiac muscle fibers ar (Figs. 1-5 ). Doxorubicin is one of the effective and widely used antineoplastic drugs indicated for treatment of many kinds of cancers either alone or in combination with other antineoplastic drugs. However, its clinical usefulness is limited by its detrimental adverse effects as cardiotoxicity which may be exaggerated to reach heart failure [25] . Cardiotoxicity is the major and the most serious adverse effect of DOX which limit its clinical usefulness. Many strategies have been tried to minimize this serious side effects by using combination treatment with cardioprotective agent and synthesis of DOX liposomes [7, 8, 9, 10, 26, 27, 28] . Among the possible potential chemosensitizer is ATX which has cytotoxic activity chemoprotective effect against chemothe adverse effects [12, 29, 32] . In our laboratory, it has been proven that ATX sensitized DOX cytotoxic activity against the growth of Ehrlich ascites carcinoma cells in-vivo shown).Therefore, our current study focus on th protective effect of ATX against DOX cardiotoxicity. The mechanisms by which DOX exerts its cardiotoxicity are not clear enough and still under investigation. Although there are several cellular pathways involved in DOX induce cardiotoxicity such as release of vasoactive substances, mitochondrial deteriorations, lipid peroxidation and depletion of the cellular antioxidants such as glutathione. As ROS liberation plays an essential role in the DOX induced cardiotoxicity we and other researchers focused on the potential involvement of ROS in DOX induced cardiotoxicity [2, 3, 4, 6, 33] ; Article no. JPRI.48804 effects as cardiotoxicity which may be exaggerated to reach heart failure major and the most serious adverse effect of DOX which limit its clinical usefulness. Among the possible potential chemosensitizer is ATX which has cytotoxic activity [29, 30, 31] and chemoprotective effect against chemotherapy . In our laboratory, it has been proven that ATX sensitized DOX cytotoxic activity against the growth of Ehrlich vivo (data not shown).Therefore, our current study focus on the protective effect of ATX against DOX-induced cardiotoxicity. The mechanisms by which DOX exerts its cardiotoxicity are not clear enough and still under investigation. Although there are several cellular pathways involved in DOX induce as release of vasoactive substances, mitochondrial deteriorations, lipid peroxidation and depletion of the cellular antioxidants such as glutathione. As ROS liberation plays an essential role in the DOX induced cardiotoxicity we and other researchers sed on the potential involvement of ROS in [2, 3, 4, 6, 33] .
It is well known that the heart tissues are highly susceptible to oxidative stress due to its inherent decreased detoxifying natural antioxidants [8, 11] .
In animal's studies, the acute cardiotoxicity induced by DOX was associated with a high level of ROS liberation and lipid peroxidation. Moreover cardiac tissues injuries are associated with elevation of the level of CPK and CK-MB enzymes. It is well known that these enzymes are released from the heart muscle cells when they are injured and their activities in the blood after myocardial injury reflect the extent of damage in its musculature [34, 35] . Our results showed that there was a significant reduction in serum total antioxidant capacity, reduced glutathione level, glutathione peroxidase level and superoxide dismutase activity in the cardiac tissues after DOX treatment (Tables 3, 5 , 6, 7). In addition, there was a significant increase in the lipid peroxidation in term of malondialdehyde level in the cardiac tissues which was significantly increased to (3.4 and 3.7 fold) 24 and 48 hrs. after DOX treatment, respectively (Table 5) .
These results are in a good agreement with others who reported the cardiac toxicity after DOX treatment. Their findings reported the decrease in the serum level of TAC and increase in the level of MDA after DOX administration in the rats' cardiac tissues [11, 36, 37, 38] .
Addition of ATX to DOX maintained the serum TAC, SOD, MDA levels and GPx level in rats hearts tissues nearly to the normal values in compare with animal treated with DOX alone.
It has been reported that the treatment with DOX increase CPK level and Ck-MB as a sequences of DOX induced cardiotoxicity as a good marker to evaluate the toxic deterioration in cardiac tissues [7, 39] .
In the present study, there was a significant increase in CPK level after 24 and 48 hrs. of DOX treatment, respectively in compare with control (Table 1) .This result was confirmed by a significant increase of the specific cardiac marker CK-MB at the same two time points tested ( Table  2) . Addition of ATX showed a cardioprotective effect against DOX induced cardiotoxicity. These findings were confirmed by a significant reduction of the total CPK levels in ATX + DOX treated rats compared with rats treated with DOX alone. This cardioprotective effect of ATX were further confirmed by a significant reduction in CK-MB level in ATX + DOX treated rats in compare with animals treated with DOX alone (Table 2) .
These results agree with Gross et al. [40] , Monroy-Ruiz et al. [41] and Binu et al. [42] who reported that ATX has a cardioprotective effect through scavenging of free radicals involved in deterioration and remodeling of cardiomyocytes and tissues such as superoxide anion and reduction of oxidative stress markers involved in cardiotoxicity from the arachidonic acid and linoleic acid pathways.
In harmony with our results, Nakao et al. [43] reported that ATX protects heart tissues damage through its antioxidant properties. Moreover, Nishigaki et al. [44] stated that ATX minimizes the glycated protein/iron chelate-induced toxicity through suppression of lipid peroxidation and protein oxidation and enhance the activity of antioxidant enzymes in human umbilical vein endothelial cells.
The current study showed that DOX-induced cardiotoxicity is minimized by quenching of ROS and hydrogen peroxide which is one of the proposed molecular mechanisms involved in the DOX induced cardiotoxicity and induction of apoptosis in cardiomyocytes [45] .
Our results are in a good agreement with Wang et al. [46] This discrepancy could be refuted as reported by Wang et al. [46] who found that DOX caused early activation of p53 in tumor cells that was followed by caspase-3 activation and DNA fragmentation. These findings suggest that the transcriptional activation of p53 in DOX-induced apoptosis in endothelial and cardiac cells may not be as crucial as it is in tumor cells. Therefore, the cytotoxicity of DOX is potentiated through over expression of p53 gene by ATX in EAC cells but not in cardiomyocytes.
Histopathological studies confirmed the biochemistry results where DOX causes loss of normal organization of cardiac muscle fibers revealing deeply acidophilic sarcoplasm and peripheral pyknotic nuclei. Moreover, numerous areas of muscle fibers shortening are noted. While, rats treated with ATX + DOX have less histopathological deteriorations (Figs. 1-5 ).
CONCLUSION
This research concluded that astaxanthin has the ability to reduce the cardiotoxic effect of DOX through inhibition of oxidative stress.
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